IriSys LLC is engaged in providing contract pharmaceutical product development and manufacturing services specializing in formulation development, cGMP (Current Good Manufacturing Practices) manufacturing of clinical trial materials and commercial pharmaceutical products, and consulting related to the drug development process. It was founded in 1996 by Gerald J. Yakatan. IriSys develops liquid-filled hard gelatin and HPMC capsule formulation technologies. Its technologies address issues related to the physical and chemical characteristics of a drug compound that include insolubility, poor bioavailability, content uniformity and sensitivity to water. The company develops formulations for new chemical entities, OTC products, generic products, and several other product candidates. It offers products in the dosage forms such as tablets, capsules, powder-filled, capsules, liquid-filled, oral solutions and suspensions, topical products, injectables, controlled release products, sustained release products, pellets, microspheres, lyophilized products, etc.